GRIFFIN STEPHEN D. (President and CEO) purchased 50.9% of their position (12.20K shares) of ANIKA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $149.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/30/2026ACC: 0001193125-26-197887
DirectorOfficer· President and CEO
Since Feb 2026
+12.20K
Net shares
Net buyer
$149.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
12.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.20K
Price / share
$12.29
Trade value
$149.88K
% of position
50.9%
4/30/2026
23.96K→36.16K
Total
Net shares
+12.20K
Net value
$149.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/30/2026 | P · Purchase | +12.20K | $12.29 | $149.88K | 50.9% | 23.96K | 36.16K |
| Total | +12.20K | $149.88K | ||||||
Derivative Transactions0
No derivative transactions reported